From Science Week: Innovative arenas create collaboration for the city of the future

In a panel discussion during Science Week on February 1, it was discussed how innovative neutral arenas are central to the development of the smart and knowledge-intensive city.

Flemingsberg Science CEO Johnny Högberg participated together with a panel consisting of Sophia Sundberg, CEO, Barkaby Science, Peter Dobers, Professor of Business Administration with a focus on sustainable development and collaboration, Södertörn University, Johan Zachrisson, Business Development Manager, Fabege and Anton Västberg, Development Director, Region Stockholm. All under the guidance of moderator Lydia Capolicchio.

Watch on Youtube.

From Milan to Flemingsberg: A CEO’s Insights on Innovation and Urban Development

Earlier this year, our CEO Johnny Högberg visited Milan together with the Mälardal Council, where they witnessed examples of how the city and region have worked with successful innovation areas such as the Milano Innovation District (MIND) and other industrial clusters. Subsequently, on April 26th, the Mälardal Council's triple helix network, the Greater Stockholm Network, held its networking meeting at Innovation Station Flemingsberg. It was an opportunity to discuss the lessons learned from the trip to Milan and the network's ongoing work to strengthen the Stockholm-Mälaren region. Johnny Högberg shares his insights.

A Pitch Workshop for Entrepreneurs and Innovators in Flemingsberg

Earlier this spring, the Flemingsberg Science Foundation hosted a pitch workshop aimed at supporting entrepreneurs and innovators with promising ideas in Flemingsberg to elevate their concepts to the next level. This workshop coincided with our prestigious competition, Flemingsberg Science Award.

NextCell Pharma: A Decade at the Forefront of the Stem Cell Revolution

For the past ten years, NextCell Pharma has been developing cell therapies for autoimmune and inflammatory diseases, operating Sweden's largest stem cell biobank through its subsidiary, Cellaviva, and conducting five clinical trials. They celebrate this milestone by launching their third subsidiary, QVance.

Do you want to know more?
Subscribe to our newsletter.

Do you want to know more?
Subscribe to our newsletter.

CF_logo_neg
2023-02-02T13:42:54+01:00
Go to Top